Article info
PDFHepatology
Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
- Correspondence to Dr Carmelo García-Monzón, Liver Research Unit, University Hospital Santa Cristina, Instituto de Investigación Sanitaria Princesa, Maestro Vives 2, 28009 Madrid, Spain; cgarcia.hscr{at}salud.madrid.org
Citation
Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
Publication history
- Revised December 9, 2010
- Accepted December 12, 2010
- First published January 26, 2011.
Online issue publication
October 26, 2017
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.